Johnson & Johnson (BCBA:JNJ)

Argentina flag Argentina · Delayed Price · Currency is ARS
14,675
+225 (1.56%)
At close: Jul 30, 2025, 5:00 PM BRT
1.56%
Market Cap520.88T
Revenue (ttm)107.61T
Net Income (ttm)26.91T
Shares Outn/a
EPS (ttm)11,083.28
PE Ratio19.36
Forward PE15.30
Dividend226.09 (1.54%)
Ex-Dividend DateMay 27, 2025
Volume12,798
Average Volume12,176
Open14,500
Previous Close14,450
Day's Range14,400 - 14,800
52-Week Range10,425 - 14,775
Beta0.40
RSI75.39
Earnings DateJul 16, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Sector Healthcare
Founded 1886
Employees 138,100
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol JNJ
Full Company Profile

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.